George Soros’s Day One Biopharmaceuticals DAWN Stock Holding History

George Soros’s Portfolio DAWN Stock Details DAWN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,539,100	Closed	-$33M	–	283
2026 Q1	$33M	Buy	+1,539,100	New	+$21.7M	0.36%	71

Other funds holding DAWN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

George Soros's DAWN Position: Q2 2026 in Review

George Soros sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 1,539,100 shares — an estimated $33M sold.

George Soros first reported a position in DAWN in Q1 2026 and held it in 1 quarter. The position peaked at $33M in Q1 2026. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.

George Soros reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
George Soros sold 1,539,100 Day One Biopharmaceuticals shares in Q2 2026, an estimated $33M.
George Soros first reported a position in Day One Biopharmaceuticals in Q1 2026 and held it in 1 quarter.
George Soros's Day One Biopharmaceuticals position peaked at $33M in Q1 2026.
1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.

Based on Soros Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.